Literature DB >> 1690974

Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study.

M S Gold1, J Russo, M Tissot, G Weinhouse, T Riles.   

Abstract

The effects of hetastarch and human albumin solutions on perioperative bleeding and coagulation parameters during abdominal aortic aneurysm repair were compared. In two randomized groups of 20 patients, albumin 5% (group 1) or hetastarch 6% (group 2) 1 g/kg was given during surgery. The remaining perioperative fluids consisted of lactated ringers and packed red blood cells. Perioperative coagulation measurements included partial thromboplastin time, prothrombin time, activated clotting time, platelet count, and bleeding time. Estimated blood loss and the total amount of crystalloid and blood infused were also measured. The surgeon, blind to the colloid used, subjectively rated bleeding on a scale of 1 to 10. There was no significant difference between groups for any measured parameter at any time. Measurements of coagulation function were within normal limits for both groups. Hetastarch does not cause clotting disorders in patients undergoing abdominal aortic aneurysm repair, at least if the quantities used in this study are not exceeded.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690974      PMCID: PMC1358036          DOI: 10.1097/00000658-199004000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Hetastarch coagulopathy in a neurosurgical patient.

Authors:  M D Cully; C P Larson; G D Silverberg
Journal:  Anesthesiology       Date:  1987-05       Impact factor: 7.892

2.  Hydroxyethyl starch accentuates von Willebrand's disease.

Authors:  R G Strauss; D C Stump; R A Henriksen
Journal:  Transfusion       Date:  1985 May-Jun       Impact factor: 3.157

3.  The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander.

Authors:  E Macintyre; I J Mackie; D Ho; J Tinker; C Bullen; S J Machin
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

4.  Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII.

Authors:  D C Stump; R G Strauss; R A Henriksen; R E Petersen; R Saunders
Journal:  Transfusion       Date:  1985 Jul-Aug       Impact factor: 3.157

5.  Hypothermia-induced reversible platelet dysfunction.

Authors:  C R Valeri; H Feingold; G Cassidy; G Ragno; S Khuri; M D Altschule
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

6.  Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization.

Authors:  J K Kirklin; W A Lell; N T Kouchoukos
Journal:  Ann Thorac Surg       Date:  1984-01       Impact factor: 4.330

7.  Coagulation, hemostasis, and plasma expanders:a quarter century enigma.

Authors:  B Alexander; K Odake; D Lawlor; M Swanger
Journal:  Fed Proc       Date:  1975-05

8.  Clinical comparison of hetastarch and albumin in postoperative cardiac patients.

Authors:  J T Diehl; J L Lester; D M Cosgrove
Journal:  Ann Thorac Surg       Date:  1982-12       Impact factor: 4.330

9.  A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness.

Authors:  D N Lockwood; C Bullen; S J Machin
Journal:  Anaesthesia       Date:  1988-05       Impact factor: 6.955

10.  Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch.

Authors:  P Belcher; S C Lennox
Journal:  Ann Thorac Surg       Date:  1984-05       Impact factor: 4.330

View more
  8 in total

1.  Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Tenon Hospital Paris.

Authors:  I Debrix; D Combeau; F Stephan; A Benomar; A Becker
Journal:  Pharm World Sci       Date:  1999-02

Review 2.  Intravenous volume replacement: which fluid and why?

Authors:  L Huskisson
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 3.  Colloid volume expanders. Problems, pitfalls and possibilities.

Authors:  J S Roberts; S L Bratton
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 4.  Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

Authors:  Xue-Yin Shi; Zui Zou; Xing-Ying He; Hai-Tao Xu; Hong-Bin Yuan; Hu Liu
Journal:  Eur J Clin Pharmacol       Date:  2011-03-02       Impact factor: 2.953

5.  Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice.

Authors:  David K Shellington; Lina Du; Xianren Wu; Jennifer Exo; Vincent Vagni; Li Ma; Keri Janesko-Feldman; Robert S B Clark; Hülya Bayir; C Edward Dixon; Larry W Jenkins; Carleton J C Hsia; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

Review 6.  Colloid solutions for fluid resuscitation.

Authors:  Frances Bunn; Daksha Trivedi
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

7.  Volume replacement strategies on intensive care units: results from a postal survey.

Authors:  J Boldt; M Lenz; B Kumle; M Papsdorf
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

Review 8.  Intravenous fluids for abdominal aortic surgery.

Authors:  Patiparn Toomtong; Sirilak Suksompong
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.